Sphera Funds Management LTD.
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Sphera Funds Management LTD. reported 92 stock positions worth $581.5 million. Its top holding was Mineralys Therapeutics (MLYS) at 6.2% of the portfolio, followed by Teva Pharmaceutical-SP ADR (TEVA, 5.9%) and Tower Semiconductor (TSEM, 4.4%). Compared with Q4 2025, it opened 19 new positions, sold out of 21, added to 30 and reduced 30. The biggest buy was Mineralys Therapeutics (MLYS, shares +198%) and the biggest sale an exit from Annexon (ANNX).
- Most Recent 13F
- Q2 2026
- Location
- TEL AVIV, L3
- CIK
- 0001496201
- Portfolio Value
- $581.5M (Q1 2026)
- SEC Filing
- 0001496201-26-000003 ↗ filed May 15, 2026
Holdings Value
Holdings 92 stocks · $581.5M
| MLYS Mineralys Therapeutics Inc. | 6.24% | 1,339,971 | $36.3M | Add +198.4% |
| TEVA Teva Pharmaceutical-SP ADR | 5.89% | 1,136,975 | $34.2M | Add +1.2% |
| TSEM Tower Semiconductor Ltd. | 4.40% | 145,735 | $25.6M | Add +18.9% |
| NVMI Nova Ltd. | 3.99% | 53,366 | $23.2M | Add +11.5% |
| BBIO Bridgebio Pharma Inc. | 3.13% | 245,246 | $18.2M | Add +127.6% |
| BIIB Biogen Inc. | 2.92% | 92,526 | $17.0M | Reduce -2.3% |
| RARE Ultragenyx Pharmaceutical Inc. | 2.92% | 809,333 | $17.0M | Add +169.2% |
| SNDX Syndax Pharmaceuticals Inc. | 2.91% | 724,563 | $16.9M | Reduce -5.0% |
| COGT Cogent Biosciences Inc. | 2.76% | 416,340 | $16.0M | Add +10.0% |
| SNY Sanofi-ADR | 2.23% | 269,515 | $13.0M | Add +12.5% |
| AZN Astrazeneca PLC | 2.12% | 62,530 | $12.3M | Reduce -7.4% |
| FOLD Amicus Therapeutics Inc. | 1.50% | 603,377 | $8.7M | Reduce -8.3% |
| CLBT Cellebrite Di Ltd. | 1.50% | 631,521 | $8.7M | New |
| APLS Apellis Pharmaceuticals Inc. | 1.49% | 214,914 | $8.6M | Reduce -14.4% |
| PANW Palo Alto Networks Inc. | 1.46% | 52,800 | $8.5M | New |
| LLY Eli Lilly & Co. | 1.43% | 9,040 | $8.3M | No change |
| BCRX Biocryst Pharmaceuticals Inc. | 1.42% | 866,464 | $8.2M | Add +3.4% |
| CAMT Camtek Ltd. | 1.38% | 53,020 | $8.0M | Add +34.2% |
| BMRN Biomarin Pharmaceutical Inc. | 1.36% | 139,900 | $7.9M | Reduce -4.8% |
| CLDX Celldex Therapeutics Inc. | 1.33% | 243,575 | $7.7M | Add +1.6% |
| ORA Ormat Technologies Inc. | 1.31% | 68,250 | $7.6M | New |
| XENE Xenon Pharmaceuticals Inc. | 1.27% | 127,000 | $7.4M | New |
| SLNO Soleno Therapeutics Inc. | 1.25% | 216,281 | $7.2M | Add +58.7% |
| TNGX Tango Therapeutics Inc. | 1.24% | 343,563 | $7.2M | Reduce -36.9% |
| JNJ Johnson & Johnson | 1.21% | 28,831 | $7.0M | Reduce -19.5% |
| SOLAR EDGE TECHNOLOGIES (SEDG 2.25 07/01/29) | 1.19% | 4,000,000 | $6.9M | No change |
| IMTX Immatics NV | 1.18% | 696,105 | $6.8M | Reduce -19.2% |
| TRVI Trevi Therapeutics Inc. | 1.18% | 574,029 | $6.8M | Reduce -4.1% |
| ORIC Oric Pharmaceuticals Inc. | 1.17% | 537,628 | $6.8M | Reduce -46.5% |
| MAZE Maze Therapeutics Inc. | 1.17% | 227,343 | $6.8M | Add +216.4% |
| GSK GSK PLC-Spon ADR | 1.16% | 122,000 | $6.7M | No change |
| AMZN Amazon.com Inc. | 1.14% | 31,940 | $6.7M | New |
| ABBV Abbvie Inc. | 1.13% | 30,256 | $6.6M | Add +19.8% |
| AAOI Applied Optoelectronics Inc. | 1.07% | 73,400 | $6.2M | New |
| ELVN Enliven Therapeutics Inc. | 1.03% | 153,265 | $6.0M | Reduce -32.4% |
| MRK Merck & Co. Inc. | 1.01% | 48,600 | $5.8M | No change |
| VOR Vor Biopharma Inc. | 0.99% | 321,917 | $5.7M | Reduce -21.6% |
| ACAD Acadia Pharmaceuticals Inc. | 0.98% | 256,202 | $5.7M | Add +20.7% |
| NVS Novartis AG-Sponsored ADR | 0.97% | 37,000 | $5.7M | No change |
| ELDN Eledon Pharmaceuticals Inc. | 0.94% | 1,772,131 | $5.5M | Reduce -16.9% |
| ENPH Enphase Energy Inc. | 0.93% | 142,419 | $5.4M | Reduce -23.6% |
| RVMD Revolution Medicines Inc. | 0.92% | 55,110 | $5.4M | Add +5.0% |
| PFE Pfizer Inc. | 0.90% | 186,000 | $5.2M | Add +116.3% |
| BHVN Biohaven Ltd. | 0.86% | 594,000 | $5.0M | New |
| FBRX Forte Biosciences Inc. | 0.82% | 184,984 | $4.8M | Reduce -0.5% |
| HELP Cybin Inc. | 0.81% | 987,090 | $4.7M | Add +19.6% |
| MDGL Madrigal Pharmaceuticals Inc. | 0.81% | 9,040 | $4.7M | Add +173.9% |
| SRRK Scholar Rock Holding Corp. | 0.80% | 94,265 | $4.6M | Reduce -40.4% |
| NVO Novo-Nordisk A/S-Spons ADR | 0.76% | 120,677 | $4.4M | Add +4.3% |
| MDWD Mediwound Ltd. | 0.76% | 273,192 | $4.4M | Add +18.6% |
| KOD Kodiak Sciences Inc. | 0.75% | 114,796 | $4.4M | Reduce -34.6% |
| ZBIO Zenas Biopharma Inc. | 0.72% | 214,334 | $4.2M | New |
| PMN Promis Neurosciences Inc. | 0.71% | 325,591 | $4.1M | Add +2657.6% |
| RLAY Relay Therapeutics Inc. | 0.70% | 408,436 | $4.1M | New |
| SVRA Savara Inc. | 0.69% | 739,164 | $4.0M | Reduce -37.3% |
| WVE Wave Life Sciences Ltd. | 0.68% | 548,272 | $4.0M | Add +34.3% |
| CRVS Corvus Pharmaceuticals Inc. | 0.62% | 247,961 | $3.6M | Reduce -39.2% |
| OVID Ovid Therapeutics Inc. | 0.62% | 1,622,828 | $3.6M | New |
| IRON Disc Medicine Inc. | 0.59% | 53,538 | $3.4M | New |
| UPB Upstream Bio Inc. | 0.55% | 358,000 | $3.2M | New |
| ACOG Alpha Cognition Inc. | 0.54% | 567,616 | $3.1M | No change |
| PALI Palisade Bio Inc. | 0.52% | 1,733,471 | $3.0M | Add +841.6% |
| DYN Dyne Therapeutics Inc. | 0.50% | 160,594 | $2.9M | Reduce -59.1% |
| CLYM Climb Bio Inc. | 0.49% | 419,247 | $2.9M | Reduce -55.0% |
| ZIM Zim Integrated Shipping Serv | 0.48% | 105,950 | $2.8M | Reduce -22.1% |
| MSLE Satellos Bioscience Inc. | 0.47% | 489,207 | $2.8M | New |
| SEDG Solaredge Technologies Inc. | 0.46% | 52,836 | $2.7M | Reduce -73.1% |
| AMGN Amgen Inc. | 0.45% | 7,500 | $2.6M | No change |
| CYTK Cytokinetics Inc. | 0.45% | 39,817 | $2.6M | Reduce -56.6% |
| GPCR Structure Therapeutics Inc. | 0.42% | 50,800 | $2.4M | Add +23.9% |
| KURA Kura Oncology Inc. | 0.41% | 295,522 | $2.4M | No change |
| GENB Generate Biomedicines Inc. | 0.40% | 185,000 | $2.3M | New |
| IBIT iShares Bitcoin Trust ETF | 0.39% | 59,505 | $2.3M | Add +98.0% |
| CTNM Contineum Therapeutics Inc. Class A | 0.39% | 173,475 | $2.3M | No change |
| TENX Tenax Therapeutics Inc. | 0.37% | 136,015 | $2.2M | Reduce -28.4% |
| PRLD Prelude Therapeutics Inc. | 0.33% | 558,339 | $1.9M | Add +354.9% |
| ASND Ascendis Pharma A/S | 0.31% | 8,000 | $1.8M | Reduce -27.3% |
| VSTM Verastem Inc. | 0.31% | 343,678 | $1.8M | No change |
| VYGR Voyager Therapeutics Inc. | 0.31% | 469,761 | $1.8M | Add +38.3% |
| STTK Shattuck Labs Inc. | 0.31% | 280,786 | $1.8M | Add +43.8% |
| EVMN Evommune Inc. | 0.31% | 78,234 | $1.8M | Reduce -52.9% |
| BIOA Bioage Labs Inc. | 0.26% | 86,518 | $1.5M | Reduce -64.4% |
| ORGO Organogenesis Holdings Inc. | 0.22% | 550,000 | $1.3M | New |
| CRIS Curis Inc. | 0.19% | 1,994,937 | $1.1M | New |
| BMY Bristol-Myers Squibb Co. | 0.18% | 17,500 | $1.1M | No change |
| CTMX Cytomx Therapeutics Inc. | 0.18% | 220,000 | $1.0M | New |
| NICE Nice Ltd. - Spon ADR | 0.11% | 5,611 | $619K | New |
| HOWL Werewolf Therapeutics Inc. | 0.09% | 626,810 | $522K | No change |
| SKYE Skye Bioscience Inc. | 0.07% | 678,928 | $417K | Add +41.8% |
| DTIL Precision Biosciences Inc. | 0.04% | 40,000 | $220K | Reduce -89.9% |
| APRE Aprea Therapeutics Inc. | 0.04% | 270,000 | $206K | No change |
| FHTX Foghorn Therapeutics Inc. | 0.01% | 12,224 | $58K | New |
Options reported separately and not counted above: XBI puts ($25.5M), CYTK calls ($17.1M), TLT calls ($4.1M), OLMA calls ($1.5M).
Portfolio Sells Q4 2025 → Q1 2026
| ANNX Annexon Inc. | Sold out | 0.00% | −1.38 |
| DYN Dyne Therapeutics Inc. | Reduce -59.1% | 0.50% | −1.11 |
| ATXS Astria Therapeutics Inc. | Sold out | 0.00% | −0.97 |
| AMD Advanced Micro Devices | Sold out | 0.00% | −0.81 |
| SVRA Savara Inc. | Reduce -37.3% | 0.69% | −0.79 |
| CYTK Cytokinetics Inc. | Reduce -56.6% | 0.45% | −0.77 |
| TARA Protara Therapeutic Inc. | Sold out | 0.00% | −0.72 |
| SEDG Solaredge Technologies Inc. | Reduce -73.1% | 0.46% | −0.72 |
| IMTX Immatics NV | Reduce -19.2% | 1.18% | −0.71 |
| AVGO Broadcom Inc. | Sold out | 0.00% | −0.71 |
| SRRK Scholar Rock Holding Corp. | Reduce -40.4% | 0.80% | −0.66 |
| ESLT Elbit Systems Ltd. | Sold out | 0.00% | −0.64 |
| BIIB Biogen Inc. | Reduce -2.3% | 2.92% | −0.57 |
| ORIC Oric Pharmaceuticals Inc. | Reduce -46.5% | 1.17% | −0.55 |
| NRIX Nurix Therapeutics Inc. | Sold out | 0.00% | −0.49 |
| AZN Astrazeneca PLC | Reduce -7.4% | 2.12% | −0.47 |
| BMRN Biomarin Pharmaceutical Inc. | Reduce -4.8% | 1.36% | −0.47 |
| FOLD Amicus Therapeutics Inc. | Reduce -8.3% | 1.50% | −0.46 |
| JANX Janux Therapeutics Inc. | Sold out | 0.00% | −0.46 |
| SNDX Syndax Pharmaceuticals Inc. | Reduce -5.0% | 2.91% | −0.44 |
| TSHA Taysha Gene Therapies Inc. | Sold out | 0.00% | −0.42 |
| BIOA Bioage Labs Inc. | Reduce -64.4% | 0.26% | −0.41 |
| TRVI Trevi Therapeutics Inc. | Reduce -4.1% | 1.18% | −0.39 |
| PHVS Pharvaris NV | Sold out | 0.00% | −0.37 |
| VRNS Varonis Systems Inc. | Sold out | 0.00% | −0.36 |
| VTYX Ventyx Biosciences Inc. | Sold out | 0.00% | −0.34 |
| JNJ Johnson & Johnson | Reduce -19.5% | 1.21% | −0.34 |
| ENPH Enphase Energy Inc. | Reduce -23.6% | 0.93% | −0.32 |
| DTIL Precision Biosciences Inc. | Reduce -89.9% | 0.04% | −0.31 |
| CLYM Climb Bio Inc. | Reduce -55.0% | 0.49% | −0.29 |
| EVMN Evommune Inc. | Reduce -52.9% | 0.31% | −0.29 |
| DAWN Day One Biopharmaceuticals I | Sold out | 0.00% | −0.28 |
| KOD Kodiak Sciences Inc. | Reduce -34.6% | 0.75% | −0.27 |
| TRDA Entrada Therapeutics Inc. | Sold out | 0.00% | −0.24 |
| FBRX Forte Biosciences Inc. | Reduce -0.5% | 0.82% | −0.24 |
| TNYA Tenaya Therapeutics Inc. | Sold out | 0.00% | −0.22 |
| CATX Perspective Therapeutics Inc. | Sold out | 0.00% | −0.20 |
| JSPR Jasper Therapeutics Inc. | Sold out | 0.00% | −0.19 |
| ASND Ascendis Pharma A/S | Reduce -27.3% | 0.31% | −0.18 |
| PEPG Pepgen Inc. | Sold out | 0.00% | −0.17 |
| VOR Vor Biopharma Inc. | Reduce -21.6% | 0.99% | −0.13 |
| ZIM Zim Integrated Shipping Serv | Reduce -22.1% | 0.48% | −0.12 |
| TENX Tenax Therapeutics Inc. | Reduce -28.4% | 0.37% | −0.11 |
| OKUR Onkure Therapeutics Inc. Class A | Sold out | 0.00% | −0.04 |
| CRVS Corvus Pharmaceuticals Inc. | Reduce -39.2% | 0.62% | −0.03 |
| MREO Mereo Biopharma Group PL-ADR | Sold out | 0.00% | −0.02 |
| APLT Applied Therapeutics Inc. | Sold out | 0.00% | −0.00 |
| APLS Apellis Pharmaceuticals Inc. | Reduce -14.4% | 1.49% | +0.17 |
| TNGX Tango Therapeutics Inc. | Reduce -36.9% | 1.24% | +0.23 |
| ELDN Eledon Pharmaceuticals Inc. | Reduce -16.9% | 0.94% | +0.27 |
Portfolio Buys Q4 2025 → Q1 2026
| MLYS Mineralys Therapeutics Inc. | Add +198.4% | 6.24% | +2.84 |
| CLBT Cellebrite Di Ltd. | New | 1.50% | +1.50 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +169.2% | 2.92% | +1.47 |
| PANW Palo Alto Networks Inc. | New | 1.46% | +1.46 |
| BBIO Bridgebio Pharma Inc. | Add +127.6% | 3.13% | +1.41 |
| TSEM Tower Semiconductor Ltd. | Add +18.9% | 4.40% | +1.39 |
| ORA Ormat Technologies Inc. | New | 1.31% | +1.31 |
| XENE Xenon Pharmaceuticals Inc. | New | 1.27% | +1.27 |
| AMZN Amazon.com Inc. | New | 1.14% | +1.14 |
| AAOI Applied Optoelectronics Inc. | New | 1.07% | +1.07 |
| BHVN Biohaven Ltd. | New | 0.86% | +0.86 |
| ZBIO Zenas Biopharma Inc. | New | 0.72% | +0.72 |
| NVMI Nova Ltd. | Add +11.5% | 3.99% | +0.70 |
| RLAY Relay Therapeutics Inc. | New | 0.70% | +0.70 |
| PMN Promis Neurosciences Inc. | Add +2657.6% | 0.71% | +0.69 |
| OVID Ovid Therapeutics Inc. | New | 0.62% | +0.62 |
| IRON Disc Medicine Inc. | New | 0.59% | +0.59 |
| UPB Upstream Bio Inc. | New | 0.55% | +0.55 |
| MAZE Maze Therapeutics Inc. | Add +216.4% | 1.17% | +0.55 |
| CAMT Camtek Ltd. | Add +34.2% | 1.38% | +0.50 |
| MSLE Satellos Bioscience Inc. | New | 0.47% | +0.47 |
| PFE Pfizer Inc. | Add +116.3% | 0.90% | +0.45 |
| PALI Palisade Bio Inc. | Add +841.6% | 0.52% | +0.43 |
| MDGL Madrigal Pharmaceuticals Inc. | Add +173.9% | 0.81% | +0.41 |
| GENB Generate Biomedicines Inc. | New | 0.40% | +0.40 |
| PRLD Prelude Therapeutics Inc. | Add +354.9% | 0.33% | +0.25 |
| ORGO Organogenesis Holdings Inc. | New | 0.22% | +0.22 |
| CRIS Curis Inc. | New | 0.19% | +0.19 |
| CTMX Cytomx Therapeutics Inc. | New | 0.18% | +0.18 |
| STTK Shattuck Labs Inc. | Add +43.8% | 0.31% | +0.16 |
| NICE Nice Ltd. - Spon ADR | New | 0.11% | +0.11 |
| IBIT iShares Bitcoin Trust ETF | Add +98.0% | 0.39% | +0.08 |
| BCRX Biocryst Pharmaceuticals Inc. | Add +3.4% | 1.42% | +0.05 |
| RVMD Revolution Medicines Inc. | Add +5.0% | 0.92% | +0.05 |
| VYGR Voyager Therapeutics Inc. | Add +38.3% | 0.31% | +0.03 |
| FHTX Foghorn Therapeutics Inc. | New | 0.01% | +0.01 |
| SKYE Skye Bioscience Inc. | Add +41.8% | 0.07% | −0.00 |
| CLDX Celldex Therapeutics Inc. | Add +1.6% | 1.33% | −0.03 |
| COGT Cogent Biosciences Inc. | Add +10.0% | 2.76% | −0.05 |
| SLNO Soleno Therapeutics Inc. | Add +58.7% | 1.25% | −0.07 |
| ABBV Abbvie Inc. | Add +19.8% | 1.13% | −0.07 |
| MDWD Mediwound Ltd. | Add +18.6% | 0.76% | −0.13 |
| GPCR Structure Therapeutics Inc. | Add +23.9% | 0.42% | −0.17 |
| SNY Sanofi-ADR | Add +12.5% | 2.23% | −0.19 |
| ACAD Acadia Pharmaceuticals Inc. | Add +20.7% | 0.98% | −0.20 |
| NVO Novo-Nordisk A/S-Spons ADR | Add +4.3% | 0.76% | −0.47 |
| HELP Cybin Inc. | Add +19.6% | 0.81% | −0.60 |
| WVE Wave Life Sciences Ltd. | Add +34.3% | 0.68% | −0.77 |
| TEVA Teva Pharmaceutical-SP ADR | Add +1.2% | 5.89% | −1.44 |
Options Activity Q4 2025 → Q1 2026
| XBI SS SPDR S&P Biotech ETF | put | Add +185.7% | 200,000 | $25.5M |
| CYTK Cytokinetics Inc. | call | New | 259,300 | $17.1M |
| PRAX Praxis Precision Medicines I | call | Sold out | 40,000 | $11.8Mbefore exit |
| RARE Ultragenyx Pharmaceutical Inc. | call | Sold out | 350,000 | $8.1Mbefore exit |
| NICE Nice Ltd. - Spon ADR | call | Sold out | 55,700 | $6.3Mbefore exit |
| OLMA Olema Pharmaceuticals Inc. | call | New | 100,000 | $1.5M |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 97 | $698.8M | TEVA, MLYS, TSEM, SNDX, BIIB |
| Q1 2026 | 92 | $581.5M | MLYS, TEVA, TSEM, NVMI, BBIO |
| Q4 2025 | 94 | $478.5M | TEVA, BIIB, MLYS, SNDX, NVMI |
| Q3 2025 | 101 | $421.6M | TEVA, NICE, TSEM, NVMI, QQQ |
| Q2 2025 | 101 | $382.5M | TEVA, NVMI, SNDX, TSEM, CYTK |
| Q1 2025 | 111 | $405.5M | TEVA, SNDX, SNY, NVMI, AZN |
| Q4 2024 | 102 | $541.4M | TEVA, BBIO, SNY, SNDX, AZN |
| Q3 2024 | 107 | $611.0M | TEVA, SNY, BBIO, SNDX, AMZN |
| Q2 2024 | 109 | $613.3M | BBIO, SNY, CYTK, AMZN, SNDX |
| Q1 2024 | 92 | $617.3M | TEVA, SNY, NICE, CYTK, SNDX |